Merck & Co., Inc.
MRK
$113.56
$1.191.06%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.94B | 18.25B | 19.03B | 16.41B | 17.43B |
| Total Depreciation and Amortization | 4.98B | 4.64B | 4.33B | 4.38B | 4.38B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.85B | 556.00M | 209.00M | 2.99B | 3.06B |
| Change in Net Operating Assets | -4.88B | -6.98B | -6.51B | -5.24B | -4.00B |
| Cash from Operations | 17.89B | 16.47B | 17.07B | 18.53B | 20.88B |
| Capital Expenditure | -3.78B | -4.11B | -4.02B | -3.81B | -3.84B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -18.82B | -10.04B | -2.00M | -3.35B | -3.35B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.00M | 413.00M | 34.00M | -387.00M | -659.00M |
| Cash from Investing | -22.46B | -13.74B | -3.98B | -7.55B | -7.85B |
| Total Debt Issued | 14.94B | 13.88B | 6.03B | 47.00M | 3.60B |
| Total Debt Repaid | -1.14B | -2.50B | -3.04B | -3.04B | -3.04B |
| Issuance of Common Stock | 230.00M | 92.00M | 57.00M | 48.00M | 109.00M |
| Repurchase of Common Stock | -4.79B | -5.08B | -4.32B | -3.44B | -2.35B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.23B | -8.18B | -8.11B | -8.03B | -7.94B |
| Other Financing Activities | -151.00M | -131.00M | -294.00M | -328.00M | -354.00M |
| Cash from Financing | 852.00M | -1.92B | -9.68B | -14.75B | -9.97B |
| Foreign Exchange rate Adjustments | 388.00M | 563.00M | 173.00M | 457.00M | 1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.33B | 1.37B | 3.57B | -3.30B | 3.06B |